ES514581A0 - Procedimiento para la obtencion de derivados de imidazol trisustituidos. - Google Patents

Procedimiento para la obtencion de derivados de imidazol trisustituidos.

Info

Publication number: ES514581A0
Authority: ES; Spain
Prior art keywords: trisustituted; procedure; obtaining; imidazole derivatives; imidazole
Prior art date: 1980-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES514581A

Other languages

English (en)

Other versions

ES8306121A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Ciba Geigy AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-07-25

Filing date

1982-07-30

Publication date

1983-05-16

1982-07-30 Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG

1983-05-16 Publication of ES514581A0 publication Critical patent/ES514581A0/es

1983-05-16 Publication of ES8306121A1 publication Critical patent/ES8306121A1/es

Status Expired legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Cosmetics (AREA)

ES514581A 1980-07-25 1982-07-30 Procedimiento para la obtencion de derivados de imidazol trisustituidos. Expired ES8306121A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH571580		1980-07-25

Publications (2)

Publication Number	Publication Date
ES514581A0 true ES514581A0 (es)	1983-05-16
ES8306121A1 ES8306121A1 (es)	1983-05-16

Family

ID=4298165

Family Applications (8)

Application Number	Title	Priority Date	Filing Date
ES504257A Expired ES8301472A1 (es)	1980-07-25	1981-07-24	Procedimiento para la obtencion de derivados de imidazol trisustituidos
ES514583A Granted ES514583A0 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514579A Expired ES8306119A1 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514584A Granted ES514584A0 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514580A Expired ES8306120A1 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514581A Expired ES8306121A1 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514585A Granted ES514585A0 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de oxazol trisustituidos.
ES514582A Expired ES8306122A1 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.

Family Applications Before (5)

Application Number	Title	Priority Date	Filing Date
ES504257A Expired ES8301472A1 (es)	1980-07-25	1981-07-24	Procedimiento para la obtencion de derivados de imidazol trisustituidos
ES514583A Granted ES514583A0 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514579A Expired ES8306119A1 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514584A Granted ES514584A0 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES514580A Expired ES8306120A1 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
ES514585A Granted ES514585A0 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de oxazol trisustituidos.
ES514582A Expired ES8306122A1 (es)	1980-07-25	1982-07-30	Procedimiento para la obtencion de derivados de imidazol trisustituidos.

Country Status (23)

Country	Link
US (1)	US4447431A (es)
EP (1)	EP0045081B1 (es)
JP (1)	JPS5756466A (es)
KR (13)	KR850000883B1 (es)
AR (1)	AR230269A1 (es)
AT (1)	ATE17349T1 (es)
AU (2)	AU7340481A (es)
CA (1)	CA1175431A (es)
DD (2)	DD201677A5 (es)
DE (1)	DE3173434D1 (es)
DK (1)	DK331881A (es)
ES (8)	ES8301472A1 (es)
FI (1)	FI812326L (es)
GB (1)	GB2080805B (es)
GR (1)	GR75287B (es)
IE (1)	IE52071B1 (es)
IL (1)	IL63410A (es)
NO (1)	NO812542L (es)
NZ (1)	NZ197828A (es)
PL (8)	PL237000A1 (es)
PT (1)	PT73424B (es)
SU (8)	SU1235454A3 (es)
ZA (1)	ZA815078B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1983002613A1 (en) *	1981-07-20	1983-08-04	Sallmann, Alfred	Trisubstituted oxazo compounds
EP0084756A1 (de) *	1982-01-22	1983-08-03	Ciba-Geigy Ag	Trisubstituierte Oxazaverbindungen
FR2633291B1 (fr) *	1988-06-27	1990-09-07	Oreal	Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant
US5252322A (en) *	1989-09-22	1993-10-12	The Gillette Company	Skin tanning compositions containing imidazoles
NZ239161A (en) *	1990-07-31	1994-01-26	Smithkline Beecham Corp	Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
IL104369A0 (en) *	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions
US5916891A (en) *	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
US5593991A (en) *	1993-07-16	1997-01-14	Adams; Jerry L.	Imidazole compounds, use and process of making
US5670527A (en) *	1993-07-16	1997-09-23	Smithkline Beecham Corporation	Pyridyl imidazole compounds and compositions
DE69433501T2 (de)	1993-11-08	2004-11-04	Smithkline Beecham Corp.	Oxazole zur behandlung von zytokinvermittelten erkrankungen
US5723477A (en) *	1994-11-10	1998-03-03	Sibia Neurosciences, Inc.	Modulators of acetylcholine receptors
IL118544A (en)	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US6369068B1 (en)	1995-06-07	2002-04-09	Smithkline Beecham Corporation	Amino substituted pyrimidine containing compounds
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
ZA9610687B (en) *	1995-12-22	1997-09-29	Smithkline Beecham Corp	Novel synthesis.
ES2205167T3 (es) *	1996-01-11	2004-05-01	Smithkline Beecham Corporation	Nuevos compuestos de imidazol sustituidos.
US6046208A (en) *	1996-01-11	2000-04-04	Smithkline Beecham Corporation	Substituted imidazole compounds
ZA97175B (en) *	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.
AP9700912A0 (en)	1996-01-11	1997-01-31	Smithkline Beecham Corp	Novel cycloalkyl substituted imidazoles
WO1997035856A1 (en) *	1996-03-25	1997-10-02	Smithkline Beecham Corporation	Novel treatment for cns injuries
WO1998007425A1 (en)	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US5929076A (en) *	1997-01-10	1999-07-27	Smithkline Beecham Corporation	Cycloalkyl substituted imidazoles
CN1211381C (zh) *	1997-04-24	2005-07-20	奥索·麦克尼尔药品公司	用于治疗炎性疾病的取代咪唑
JP2002504909A (ja)	1997-06-13	2002-02-12	スミスクライン・ビーチャム・コーポレイション	新規な置換ピラゾールおよびピラゾリン化合物
CA2294137A1 (en)	1997-06-19	1998-12-23	Smithkline Beecham Corporation	Novel aryloxy substituted pyrimidine imidazole compounds
TW517055B (en)	1997-07-02	2003-01-11	Smithkline Beecham Corp	Novel substituted imidazole compounds
US6489325B1 (en)	1998-07-01	2002-12-03	Smithkline Beecham Corporation	Substituted imidazole compounds
AU8381098A (en)	1997-07-02	1999-01-25	Smithkline Beecham Corporation	Novel cycloalkyl substituted imidazoles
US7301021B2 (en) *	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
AR016294A1 (es) *	1997-07-02	2001-07-04	Smithkline Beecham Corp	Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
US6562832B1 (en)	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
US6362193B1 (en)	1997-10-08	2002-03-26	Smithkline Beecham Corporation	Cycloalkenyl substituted compounds
EP1037639A4 (en)	1997-12-19	2002-04-17	Smithkline Beecham Corp	HETEROARYL-SUBSTITUTED IMIDAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES
BR9910621A (pt) *	1998-05-22	2001-01-30	Smithkline Beecham Corp	Novos compostos de imidazol 2-alquil substituìdos
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
JP2003525201A (ja) *	1998-08-20	2003-08-26	スミスクライン・ビーチャム・コーポレイション	新規な置換トリアゾール化合物
EP1126852B1 (en) *	1998-11-04	2004-01-21	SmithKline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
WO2000029399A1 (en) *	1998-11-12	2000-05-25	Boehringer Ingelheim (Canada) Ltd.	Antiherpes compounds
US6239279B1 (en)	1998-12-16	2001-05-29	Smithkline Beecham Corporation	Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
US7026336B1 (en)	1999-11-22	2006-04-11	Smithkline Beecham P.L.C.	Compounds
AU1783201A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
US6759410B1 (en) *	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
AU1781601A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
AU1782301A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p39 kinase inhibitors
US7235551B2 (en) *	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
ES2218391T3 (es) *	2000-03-06	2004-11-16	Smithkline Beecham Plc	Derivados de imidazol como inhibidores de raf-cinasa.
GB0005357D0 (en)	2000-03-06	2000-04-26	Smithkline Beecham Plc	Compounds
JP4524072B2 (ja) *	2000-10-23	2010-08-11	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー	新規化合物
GB0112348D0 (en) *	2001-05-19	2001-07-11	Smithkline Beecham Plc	Compounds
WO2003022837A1 (en) *	2001-09-05	2003-03-20	Smithkline Beecham P.L.C.	Heterocycle-carboxamide derivatives as raf kinase inhibitors
TW200505446A (en) *	2003-01-17	2005-02-16	Fuj Isawa Pharmaceutical Co Ltd	Inhibitor of cox
US20070043084A1 (en) *	2003-05-08	2007-02-22	Astellas Pharma Inc.	1,2-Diarylimidazoles useful as inhibitors of cox
AR053346A1 (es)	2005-03-25	2007-05-02	Glaxo Group Ltd	Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38
CA2603163A1 (en) *	2005-03-25	2006-10-05	Glaxo Group Limited	Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives
WO2013049272A2 (en)	2011-09-29	2013-04-04	Theraceutix, Llc	Composition and method for treatment of symptoms associated with various skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3558645A (en) *	1968-07-08	1971-01-26	Sandoz Ag	2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids
CH561717A5 (es) *	1971-05-10	1975-05-15	Ciba Geigy Ag
GB1469532A (en) *	1973-06-28	1977-04-06	Dumex Ltd As	Imimdazolyl-alkanoic acid derivatives
US4372964A (en) *	1980-10-30	1983-02-08	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols

1981
- 1981-07-23 GR GR65613A patent/GR75287B/el unknown
- 1981-07-23 DD DD81232030A patent/DD201677A5/de unknown
- 1981-07-23 CA CA000382377A patent/CA1175431A/en not_active Expired
- 1981-07-24 AU AU73404/81A patent/AU7340481A/en not_active Abandoned
- 1981-07-24 NZ NZ197828A patent/NZ197828A/en unknown
- 1981-07-24 NO NO812542A patent/NO812542L/no unknown
- 1981-07-24 ES ES504257A patent/ES8301472A1/es not_active Expired
- 1981-07-24 ZA ZA815078A patent/ZA815078B/xx unknown
- 1981-07-24 PT PT73424A patent/PT73424B/pt unknown
- 1981-07-24 IE IE1680/81A patent/IE52071B1/en unknown
- 1981-07-24 GB GB8122920A patent/GB2080805B/en not_active Expired
- 1981-07-24 IL IL63410A patent/IL63410A/xx unknown
- 1981-07-24 DK DK331881A patent/DK331881A/da not_active Application Discontinuation
- 1981-07-24 FI FI812326A patent/FI812326L/fi not_active Application Discontinuation
- 1981-07-24 SU SU813317053A patent/SU1235454A3/ru active
- 1981-07-25 PL PL23700081A patent/PL237000A1/xx unknown
- 1981-07-25 PL PL23700381A patent/PL237003A1/xx unknown
- 1981-07-25 PL PL23700481A patent/PL237004A1/xx unknown
- 1981-07-25 JP JP56115896A patent/JPS5756466A/ja active Pending
- 1981-07-25 PL PL23700181A patent/PL237001A1/xx unknown
- 1981-07-25 KR KR1019810002709A patent/KR850000883B1/ko active
- 1981-07-25 PL PL23700581A patent/PL237005A1/xx unknown
- 1981-07-25 PL PL23700281A patent/PL237002A1/xx unknown
- 1981-07-25 PL PL23699781A patent/PL236997A1/xx unknown
- 1981-07-25 PL PL1981232352A patent/PL135822B1/pl unknown
- 1981-07-27 DE DE8181105914T patent/DE3173434D1/de not_active Expired
- 1981-07-27 AT AT81105914T patent/ATE17349T1/de not_active IP Right Cessation
- 1981-07-27 EP EP81105914A patent/EP0045081B1/de not_active Expired
1982
- 1982-07-21 SU SU823465356A patent/SU1205764A3/ru active
- 1982-07-21 SU SU823466066A patent/SU1145928A3/ru active
- 1982-07-21 SU SU823465351A patent/SU1138023A3/ru active
- 1982-07-21 SU SU823466067A patent/SU1227112A3/ru active
- 1982-07-30 SU SU823468675A patent/SU1169534A3/ru active
- 1982-07-30 DD DD82242110A patent/DD202554A5/de unknown
- 1982-07-30 ES ES514583A patent/ES514583A0/es active Granted
- 1982-07-30 ES ES514579A patent/ES8306119A1/es not_active Expired
- 1982-07-30 ES ES514584A patent/ES514584A0/es active Granted
- 1982-07-30 ES ES514580A patent/ES8306120A1/es not_active Expired
- 1982-07-30 ES ES514581A patent/ES8306121A1/es not_active Expired
- 1982-07-30 ES ES514585A patent/ES514585A0/es active Granted
- 1982-07-30 SU SU823469534A patent/SU1152520A3/ru active
- 1982-07-30 ES ES514582A patent/ES8306122A1/es not_active Expired
- 1982-09-28 US US06/425,603 patent/US4447431A/en not_active Expired - Fee Related
- 1982-11-22 AR AR291374A patent/AR230269A1/es active
1983
- 1983-07-19 SU SU833618708A patent/SU1205763A3/ru active
1984
- 1984-09-27 KR KR1019840005965A patent/KR850000888B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005960A patent/KR850000873B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005964A patent/KR850000887B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005963A patent/KR850000886B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005971A patent/KR850000892B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005972A patent/KR850001064B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005962A patent/KR850000885B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005969A patent/KR850000891B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005968A patent/KR850000890B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005966A patent/KR850000889B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005961A patent/KR850000884B1/ko active IP Right Grant
- 1984-09-27 KR KR1019840005970A patent/KR850000911B1/ko active IP Right Grant
1986
- 1986-04-23 AU AU56555/86A patent/AU5655586A/en not_active Abandoned

Also Published As

Publication number	Publication date
KR850000886B1 (ko)	1985-06-26
IE52071B1 (en)	1987-06-10
EP0045081A2 (de)	1982-02-03
ES514579A0 (es)	1983-05-16
KR850000892B1 (ko)	1985-06-26
PL135822B1 (en)	1985-12-31
KR850000885B1 (ko)	1985-06-26
DE3173434D1 (en)	1986-02-20
PL237003A1 (en)	1983-02-28
GR75287B (es)	1984-07-13
KR850000883B1 (ko)	1985-06-26
JPS5756466A (en)	1982-04-05
ES8306123A1 (es)	1983-05-16
KR850000873B1 (ko)	1985-06-22
KR850002744A (ko)	1985-05-15
AU5655586A (en)	1986-09-11
KR850000889B1 (ko)	1985-06-26
KR850000884B1 (ko)	1985-06-26
KR850002745A (ko)	1985-05-15
PL237002A1 (en)	1983-02-28
KR850002749A (ko)	1985-05-15
KR850002756A (ko)	1985-05-15
PL232352A1 (es)	1982-12-20
NZ197828A (en)	1985-11-08
KR850000887B1 (ko)	1985-06-26
ES514580A0 (es)	1983-05-16
SU1227112A3 (ru)	1986-04-23
KR850000891B1 (ko)	1985-06-26
SU1235454A3 (ru)	1986-05-30
PL236997A1 (en)	1983-01-03
ES514582A0 (es)	1983-05-16
KR850002753A (ko)	1985-05-15
KR850000911B1 (ko)	1985-06-27
SU1138023A3 (ru)	1985-01-30
SU1145928A3 (ru)	1985-03-15
US4447431A (en)	1984-05-08
IL63410A (en)	1986-04-29
AR230269A1 (es)	1984-03-01
ES504257A0 (es)	1982-12-01
SU1205763A3 (ru)	1986-01-15
GB2080805B (en)	1984-03-07
PT73424B (en)	1983-06-20
KR850001064B1 (ko)	1985-07-25
PL237000A1 (en)	1983-02-28
KR850002755A (ko)	1985-05-15
DD201677A5 (de)	1983-08-03
IE811680L (en)	1982-01-25
ES8306122A1 (es)	1983-05-16
IL63410A0 (en)	1981-10-30
ES8306119A1 (es)	1983-05-16
ZA815078B (en)	1982-07-28
KR850002752A (ko)	1985-05-15
KR850002750A (ko)	1985-05-15
EP0045081A3 (en)	1982-04-07
SU1205764A3 (ru)	1986-01-15
ATE17349T1 (de)	1986-01-15
PL237005A1 (en)	1983-02-28
CA1175431A (en)	1984-10-02
ES8307245A1 (es)	1983-07-01
KR850002748A (ko)	1985-05-15
KR850002747A (ko)	1985-05-15
FI812326L (fi)	1982-01-26
ES8306124A1 (es)	1983-05-16
KR850002754A (ko)	1985-05-15
ES8306120A1 (es)	1983-05-16
ES514584A0 (es)	1983-05-16
KR850000890B1 (ko)	1985-06-26
AU7340481A (en)	1982-01-28
KR850002746A (ko)	1985-05-15
PL237004A1 (en)	1983-02-28
ES514583A0 (es)	1983-05-16
SU1169534A3 (ru)	1985-07-23
NO812542L (no)	1982-01-26
ES8301472A1 (es)	1982-12-01
ES8306121A1 (es)	1983-05-16
PL237001A1 (en)	1983-02-28
SU1152520A3 (en)	1985-04-23
KR850000888B1 (ko)	1985-06-26
PT73424A (en)	1981-08-01
GB2080805A (en)	1982-02-10
DK331881A (da)	1982-01-26
KR830006230A (ko)	1983-09-20
EP0045081B1 (de)	1986-01-08
ES514585A0 (es)	1983-07-01
DD202554A5 (de)	1983-09-21

Publication	Publication Date	Title
ES514580A0 (es)	1983-05-16	Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES523709A0 (es)	1984-10-01	Procedimiento para la preparacion de derivados de imidazol.
AR223315A1 (es)	1981-08-14	Procedimiento para la fabricacion de derivados de 2-guanidin-(tiazol o imidazol)
ES513228A0 (es)	1983-08-01	Un procedimiento para la preparacion de una composicion de derivados del imidazol.
ES504791A0 (es)	1983-04-01	Procedimiento para la preparacion de derivados de caprolactama.
ES528181A0 (es)	1986-09-01	Procedimiento para la obtencion de derivados de imidazol (i,5-a)-piridina
ES498208A0 (es)	1981-12-01	Procedimiento para la obtencion de derivados de triazolilfe-nacil-piridil-eter, de efecto fungicida
ES515031A0 (es)	1983-06-01	Procedimiento para la obtencion de derivados de azolil-fenoxisustituidos.
ES510875A0 (es)	1983-04-16	Un procedimiento para la preparacion de un derivado del imidazol.
ES518271A0 (es)	1984-02-16	Procedimiento para la preparacion de derivados de tiazolina.
ES511317A0 (es)	1983-02-16	Procedimiento para preparar derivados de imidazol.
ES513392A0 (es)	1983-03-16	Procedimiento para la obtencion de derivados de 2-amino-piridina sustituidos.
ES537959A0 (es)	1985-10-01	Procedimiento para preparar derivados de imidazol.
ES498364A0 (es)	1982-06-01	Un procedimiento para la preparacion de derivados del imidazol.
ES513169A0 (es)	1984-07-01	Procedimiento para la obtencion de nuevos derivados de benzazol.
ES514482A0 (es)	1983-05-01	Procedimiento para la obtencion de derivados de diaril-imidazol.
ES502162A0 (es)	1982-10-01	Procedimiento para la obtencion de derivados del imidazol.
ES530042A0 (es)	1985-04-16	Procedimiento para la obtencion de derivados de imidazol conteniendo azufre
ES506911A0 (es)	1982-08-16	Procedimiento para la obtencion de derivados pirazolicos de la oximinociano-acetamida de efecto fungicida.
ES539306A0 (es)	1986-06-01	Procedimiento para preparar derivados de imidazol con actividad antitrombotica.
ES501700A0 (es)	1982-02-16	Procedimiento para la preparacion de derivados de imidazol
ES522859A0 (es)	1984-07-01	Procedimiento para la obtencion de derivados de trifluormetilfenoxi-fenilo.
MX6968E (es)	1987-01-09	Procedimiento para preparar salicilato de imidazol
ES523287A0 (es)	1984-03-16	Procedimiento para la obtencion de hidantoinas n-sulfeniladas.
ES519843A0 (es)	1984-04-01	Procedimiento para la obtencion de derivados de tetrahicro-2 pirimidona metil-sustituidos.